ArticleMolecular cancer therapeutics2018

Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers.

Joel D Maust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.